References
- Bolinder J., Fernlund P., Borg H., Arnqvist H. J., Björk E., Blohmé G., et al. Hyperproinsulinemia segregates young adult patients with newly‐diagnosed autoimmune (type 1) and non‐autoimmune (type 2) diabetes. Scand J Clin Lab Invest 2005; 7: 585–94
- Davies M. J., Rayman G., Gray I. P., Day J. L., Hales C. N. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabet Med 1993; 10: 313–20
- Ward W. K., LaCava E. C., Paquette T. L., Beard J. C., Wallum B. J., Porte D Jr. Disproportionate elevation of immunoreactive proinsulin in Type II (non‐insulin‐dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 1997; 30: 698–702
- Haffner S. M., Gonzalez C., Mykkänen L., Stern M. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study. Diabetologia 1997; 40: 830–7
- Røder M. E., Knip M., Hartling S. G., Krjalainen J., Åkerblom H. K., Bincer C. Disproportionally elevated proinsulin levels precede the onset of insulin‐dependent diabetes mellitus in siblings with low first phase insulin responses. The Childhood Diabetes in Finland Study Group. J Clin Endocrinol Metab 1994; 79: 1570–5
- Narendran P., Mannering S. I., Harrison L. C. Proinsulin – a pathogenic autoantigen in type 1 diabetes. Autoimmun Rev 2003; 2: 204–10
- Haffner S. M., Mykkänen L., Robbins D., Valdez R., Miettinen H., Howard B. V., et al. A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non‐diabetic subjects. Diabetologia 1995; 38: 1328–36
- Mohamed‐Ali V., Gould M. M., Gillies S., Goubet S., Yudkin J. S., Haines A. P. Association of proinsulin‐like molecules with lipids and fibrinogen in non‐diabetic subjects – evidence against a modulating role for insulin. Diabetologia 1995; 38: 1110–16
- Pfützner A., Kunt T., Hohberg C., Mondok A., Pahler S., Konrad T., et al. Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes. Diabets Care 2004; 27: 682–7
- Zethelius B., Lithell H., Hales C. N., Berne C. Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population‐based 10‐year, follow‐up study in 70‐year‐old men using the euglycemic insulin clamp. Diabetologia 2005; 48: 862–7
- Schneider D. J., Nordt T. K., Sobel B. E. Stimulation by proinsulin of expression of plasminogen activator inhibitor‐1 in endothelial cells. Diabetes 1992; 41: 890–5
- Nordt T. K., Schneider D. J., Sobel B. E. Augmentation of the synthesis of plasminogen activator inhibitor type‐1 by precursors of insulin. A potential risk factor for vascular disease. Circulation 1994; 89: 321–30
- Du X. L., Sui G. Z., Stockklauser‐Färber K., Weiß J., Zink S., Schwippert B., et al. Induction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species. Diabetologia 1998; 41: 249–56
- Ohyama Y., Utsugi T., Uchiyama T., Hanaoka T., Hasegawa A., Tomono S., et al. The elevated proinsulin‐to‐insulin ratio is associated with oxidative stress in Down's syndrome. Diabetologia 2001; 44: 788–9